Resultados de la búsqueda 1801-1810 of 19603 for WHO
... who have normal risk factors in order to improve the ability to diagnose and treat these cancers. We will use information in the medical record in this ...
... who have previously received 177Lu-DOTATATE for midgut neuroendocrine tumor (NET) that has spread from where it first started (primary site) to other places ...
... who have failed 1-2 prior lines of therapy. The primary objectives are to determine the maximum tolerated dose (MTD) or highest protocol-defined dose (HPDD); ...
... who have received at least two prior lines of therapies. The study has 2 Modules: Module 1 for FL and Module 2 for DLBCL. Global Cardio Oncology Registry.
Also, to improve disease control by decreasing the number of spinal relapses for patients who achieve a complete response (CR) or partial response (PR) and ...
Welcome to the AABIP―Who we are. American Association for Bronchology and Interventional Pulmonology. http://aabronchology.org/about/. Accessed Jan. 25 ...
Infórmate sobre cómo realizar la prueba para saber si estás infectado por el virus que causa la COVID-19.
... who are candidates for active surveillance and are undergoing voluntary ... who have metastatic or locally advanced solid tumors. Numeración de páginas ...
Mayo Clinic no respalda compañías ni productos. Las recaudaciones de los avisos comerciales financian nuestra misión sin fines de lucro.
Consulta estos éxitos de venta y ofertas especiales en libros y boletines informativos de Mayo Clinic Press.
¿Te gustaría hacer una donación deducible de impuestos y ser parte de una investigación de vanguardia y de una atención médica que transforma la medicina?